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Cognitive impairment is one of the most common consequences of epilepsy and has a major impact on the 
patient's life. Temporal lobe epilepsy is the most common type of focal epilepsy and is reported to be closely 
associated with cognitive impairment. Patients with other focal epilepsy syndromes such as frontal, parietal, 
and occipital lobe epilepsy are also known to experience cognitive impairment, although studies are not as 
numerous as temporal lobe epilepsy. The relationship between certain epileptic foci and complications of 
cognitive impairment in patients is not yet certain. This study was conducted to determine the correlation 
between cognitive function and the location of focal epilepsy in the neurology clinic of  RSUP Dr. 
Mohammad Hoesin (RSMH) Palembang. 
This research is an analytic observational study with a cross sectional approach. This research was conducted 
at the RSMH Palembang to collect secondary data from medical records of outpatients between 1 January 
2019-31 December 2019 and at the Neurology Clinic to collect primary data on patients seeking treatment 
between 1 July-31 August 2020. Focal epilepsy location data based on clinical syndrome, age of epilepsy 
onset, gender, education, frequency and duration of seizures, duration of epilepsy, type of antiepileptic drugs 
(AED), and duration of consuming AED were obtained through medical record and cognitive function was 
examined using the validated Indonesian version of the Montreal Cognitive Assessment (MoCA-Ina).  From 
42 samples, 29 people (69%) had decreased cognitive function and only 13 people (31%) had normal 
cognitive function. The correlation analysis between cognitive function and focal epilepsy location resulted 
in correlation coefficient of 0.107 (weak correlation) with p value of 0.365 (not significant). Other factors 
such as age of onset, level of education, frequency of seizures, duration of seizures, type of treatment, 
duration of epilepsy and duration of taking AED were also not associated with cognitive function of patients 
in this study. Many factors have been reported to affect cognitive function in epileptic patients, so it is 
unlikely that one single factor can be sole factor causing cognitive impairment in epilepsy patients. 
 




According to the Indonesian 
Association of Neurology Specialists, 
epilepsy is defined as a brain disorder 
characterized by a tendency to cause 
continuous epileptic seizures with various 
consequences, one of which is cognitive.1 
Cognitive abnormalities are among the 
most common and severe comorbidities of 
epilepsy. It is reported that 30% -40% of 
epilepsy patients experience impaired 
cognitive function.2 Epilepsy patients, 
especially those resistant to 
pharmacotherapy or who have seizures 
from an early age, are at increased risk of 
mental retardation, learning disabilities and 
memory impairments. This cognitive 
comorbidity greatly affects the quality of 
life of patients with epilepsy because it has 
a major impact on the patient's educational 
process and life-long achievement.3 
The association of cognitive 
function and epilepsy has been most studied 
in temporal lobe epilepsy because this 
syndrome is the most common cause of 
focal epilepsy. In addition, Bonn et al 
reported that 80% of pharmacoresistant 
epilepsy patients were those with temporal 
lobe epilepsy. Temporal lobe epilepsy also 
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generally manifests early (early onset) and 
the patient often has a history of febrile 
seizures, this long total duration of seizures 
increases the likelihood of cognitive 
impairment. Impaired cognitive function in 
temporal lobe epilepsy is reported to cover 
many domains including memory, 
executive function, language, and 
processing speed.4.5 
 Frontal lobe epilepsy is the second 
most common type of focal epilepsy (20-
30%). Frontal lobe epilepsy is also the 
second most common cause of 
pharmacoresistence seizures (15%).6 
Although there are fewer studies than those 
with temporal lobe epilepsy, the available 
data show that frontal lobe epilepsy patients 
may experience memory problems 
(especially working memory), social 
cognition, and attention, while intelligence 
is generally still normal.6-8 . The features of 
cognitive function in other focal epilepsy 
syndromes, namely parietal and occipital 
lobe epilepsy, have not been widely 
reported because of their low prevalence. 
Parietal lobe epilepsy syndrome is present 
in 5-6% of patients with focal epilepsy. 
Occipital lobe epilepsy is not much 
different, being the cause of 5-8% of focal 
epilepsy.9  The studies available so far 
report cognitive impairment in the spatial 
domain, orientation, touch perception, 
constructional apraxia and neglect in 
patients with parietal lobe epilepsy. Other 
studies have shown an association between 
seizures originating in the right parietal 
lobe and deficits in spatial and 
constructional function and anosgnosia, 
whereas seizures of the left parietal lobe 
cause impaired reading, writing, and 
calculations or generally affect the patient's 
verbal ability.9 Piazzini et al reported that 
some patients with occipital lobe epilepsy 
had mild problems with naming. Bilo et al 
also reported the presence of complex 
visuospatial disorders, constructional 
abilities and executive function in patients 
with occipital lobe epilepsy. In addition, 
cortical blindness, simultanagnosia, and 
visual hallucinations have also been 
reported in patients with occipital lobe 
epilepsy.10-11 
Many factors have been reported to 
increase the risk of epilepsy patients 
developing cognitive impairments. In 
addition to the pathogenesis of epilepsy 
itself, namely the epileptogenic focus as 
described in the previous paragraph, other 
factors such as the duration of epilepsy, the 
adverse effects of AED, and the educational 
level of patients have also been reported to 
have an effect on cognitive dysfunction.3 
This study aims to find out whether a 
particular focus of epilepsy is definitely 
associated with cognitive impairment in 
patients because the available studies are 
generally carried out separately according 





This research is an analytic 
observational study with a cross sectional 
approach. This research is conducted at the 
Medical Record Installation of Dr. Moh. 
Hoesin (RSMH) Palembang to collect data 
on patients who came for medical treatment 
between 1 January 2019-31 December 2019 
and also at the Neurology Clinic to collect 
data on patients undergoing treatment 
between 1 July-31 August 2020. The total 
sampling method was applied in this study. 
All subjects who meet the inclusion criteria, 
namely (a) age ≥18 years, (b) diagnosed 
with focal epilepsy syndrome through 
clinical symptoms, (c) have received 
epilepsy treatment, and (d) have undergone 
MoCA-Ina examination and the results are 
recorded in medical records (for secondary 
data) will all be included as study samples. 
Subjects with unreadable / damaged / 
missing medical records, illiterate, deaf / 
speech impaired or experiencing decreased 
consciousness were excluded from this 
study. Data on independent variables such 
as location of focal epilepsy based on 
clinical syndrome, age of epilepsy onset, 
sex, education, frequency and duration of 
seizures, type of treatment and duration of 
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epilepsy and AED were obtained through 
medical record, while data on the dependent 
variable, namely cognitive function, was 
examined using the validated Indonesian 
version of the Montreal Cognitive 
Assessment (MoCA-Ina). The data was 
processed using SPSS for windows. This 
research had been declared to be ethically 
appropriate by Health Research Ethics 





 During the months of July-August 
2020, there were only 3 subjects who met 
the inclusion criteria of the study, while 
through the search for medical records, 
there were 39 subjects, so that overall there 
were 42 research samples. Of these 42 
samples, 18 people (42.9%) had frontal 
lobe epilepsy syndrome, 17 people (40.5%) 
had temporal lobe epilepsy syndrome, 4 
people (9.5%) had occipital lobe epilepsy 
syndrome and 3 people ( 7.1%) had parietal 
lobe epilepsy syndrome. 
 The table below describes the 
characteristics of the study sample based on 
the location of the focal epilepsy they 
experienced. It can be seen that the majority 
of focal epilepsy syndromes (64.3%) were 
experienced by patients since they were less 
than 18 years of age. Male patients (59.5%) 
were slightly more than female patients 
(40.5%).  
 
Table 1. Characteristics of Subjects by Location of Focal Epilepsy 
 
Variable 














Age of Onset 
<18 years  
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 ≥1x / month 
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*Chi Square test 
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Most of the patients with focal 
epilepsy syndrome in this study had 
completed their basic education (76.2%). 
At the onset of focal epilepsy, most of the 
patients had seizures ≥1 times / month 
(62%) with a duration of less than 15 
minutes (83.3%). More temporal, parietal 
and occipital epilepsy patients who 
consumed more than one type of AED 
(polytherapy) with a percentage of 64.7%, 
66.7%, and 75%, respectively. Otherwise, 
the percentage of frontal lobe epilepsy 
patients who received only one drug 
(monotherapy) was slightly higher than 
those who received polytherapy, amounting 
to 55.6% and 44.4%, respectively. Most of 
the patients in this study had epilepsy for ≥5 
years (69%) and consumed OAE ≥2 years 
(90.1%). When bivariate analysis was 
performed, all of these variables did not 
show a significant relationship with the 
type of focal epilepsy syndrome. 
The characteristics of research 
subjects based on their cognitive function 
can be seen in the table below. Focal 
epilepsy patients with decreased cognitive 
function (69%) were more than patients 
whose cognitive function was still normal 
(31%). Patients who experienced a decline 
in cognitive function were mostly from the 
age group of onset <18 years (62.1%) and 
male (65.5%).  
   
Table 2. Characteristics of Subjects based on Degree of Cognitive Function 
 
Variable 
n (%)  
Total 
 







n (%) (CI 95%) p value 
Age of Onset 
<18 years  


















































Frequency of seizure 
≥1x / month 















Duration of seizure 
≥15 minutes 























































Duration of OAE 
consumption 
a. ≥2 years 






















aChi Square test, bFischer exact test 
Majalah Kedokteran Sriwijaya  





The proportion of patients with a 
higher level of education and decreased 
cognitive function (65.6%) was greater than 
that of patients with the same education 
level but still normal cognitive function 
(34.4%). Most of the focal epilepsy patients 
with decreased cognitive function 
experienced seizures that were quite 
frequent, ≥1 times / month (65.5%) with a 
duration of  <15 minutes (79.3%). The 
number of patients who received 
polytherapy was more than those who 
received monotherapy, both in the group of 
patients whose cognitive function was still 
normal (61.5%) and those who had 
decreased (55.2%). The majority of focal 
epilepsy patients with decreased cognitive 
function had epilepsy for ≥5 years (62%) 
and had consumed OAE for ≥2 years 
(86.2%). In the bivariate analysis, none of 
the variables had a significant relationship 
with cognitive function. 
Patients with temporal, frontal and 
occipital lobe epilepsy mostly experienced 
a decline in cognitive function with the 
proportion of 76.5%, 66.7%, and 75% 
respectively, whereas in parietal lobe 
epilepsy the opposite occurred where the 
number of patients whose cognitive 
function is still normal (66.7%) greater than 




Table 3. Relationship between Focal Epilepsy Location and Cognitive Function 
Locations of Focal Epilepsy  Cognitive function Total 
Decreased 
 (MoCA-Ina score <26) 
Normal  
(MoCA-Ina score ≥26) 
Temporal  13 (76.5%) 4 (23.5%) 17 (100%) 
Frontal  12 (66.7%) 6 (33.3%) 18 (100%) 
Parietal  1 (33.3%) 2 (66.7%) 3 (100%) 
Occipital  3 (75%) 1 (25%) 4 (100%) 
 
 
When analyzed to determine the correlation 
between the location of focal epilepsy and 
cognitive function using Somer's test, a 
correlation coefficient of 0.107 was 
obtained, which indicates a weak 
correlation with a significance value of 
0.365 which means this correlation is not 
statistically significant. In addition, a 
multiple stepwise logistic regression test 
was also carried out to determine the 
relationship between the location of focal 
epilepsy and cognitive function by 
considering the influence of other factors 
but there was not any variable that was 
related to the cognitive function of focal 
epilepsy patients in this study. However, 
the mean MoCA-Ina score of all patients 
(22.10 ± 5.378) was lower than the normal 
range (≥26). 
 
4.  DISCUSSION 
 
 Seizures are not the only problem 
faced by epilepsy patients, but there are 
various other common and quite severe 
comorbidities; cognitive disorders such as 
decreased memory and attention function, 
mental health disorders such as depression 
and anxiety, and somatic disorders such as 
migraines and sleep disorders. These 
comorbidities are often seen as more 
troublesome than the seizure itself. Among 
the various comorbidities experienced by 
these epilepsy patients, cognitive 
abnormalities were the most common.12  
There were 69% of patients who 
experienced a decline in cognitive function 
in this study, which is higher from the 
Kumar and Vatsala report who found 
cognitive impairment in only 36% of their 
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study subjects. This difference can be 
caused by differences in the sample. This 
study only included subjects with focal 
epilepsy syndrome while the Kumar and 
Vatsala study included subjects with 
various types of seizures.13 
 In this study, although there was no 
statistical association, the number of 
patients who experience cognitive decline 
is more in the group who have had epilepsy 
since the age of <18 years compared with 
those whose epilepsy onset occurs at age 
≥18 years. Past studies, including one 
reported by Farwell et al have found a 
higher incidence of low IQ in children with 
epilepsy than in healthy children. In 
addition, children with pharmacoresistant 
seizures tended to have lower IQs than 
children who responded well to epilepsy 
treatment. However, Thompson and 
Duncan in 2005 and Bell et al in 2011 
reported that adults with chronic epilepsy 
are also prone to experiencing cognitive 
regression.2 
 Most of the focal epilepsy patients 
with cognitive impairment in this study 
were male. Overall, the sex proportion of 
subjects in this study was more male than 
female (25 vs 17), similar to that reported 
by Moorthy et al (63 vs 37).14 This study 
did not find a significant relationship 
between the education level of patients with 
cognitive function, in contrast to the report 
by Wang et al that higher education level is 
a protective factor for the cognitive 
function of patients with epilepsy. Study of 
Wang et al used more than one 
neurocognitive examination methods 
including mini mental state examination / 
MMSE, verbal fluency test, digit span test 
and digital symbol test in addition to the 
MoCA-Ina, whereas cognitive function in 
this study was only based on the MoCA-Ina 
score. This difference in method may be the 
cause of the discrepancy in the results 
obtained.3 
 The proportion of focal epilepsy 
patients who experienced a decline in 
cognitive function in this study was greater 
in the group whose seizure frequency was 
higher (≥1 times / month) and had longer 
duration of epilepsy (≥5 years), although 
the duration of seizures was shorter (<15 
minutes). The study by Kumar and Vatsala 
also found no significant association 
between seizure frequency and cognitive 
function, similar to this study.13 However, 
that study also found a lower mean 
cognitive score in the group of patients 
whose higher seizure frequency than in the 
group with a lower frequency of seizures. 
Studies show that recurrent and prolonged 
seizures (status epilepticus) produce 
morphological and functional changes in 
neural circuits that directly affect the brain's 
ability to process information normally. In 
experimental animals that are induced to 
experience status epilepticus, there is 
neuronal loss of both main cells and 
interneurons throughout the hippocampus, 
parahipocampus and entorhinal cortex. 
After the death of these cells, synaptic 
reorganization is formed with abnormal 
growth in the form of sprouting of axon 
granule cells (mossy fibers). Sprouting and 
formation of new synapses also occur in 
pyramidal neurons. These newly formed 
synapses cause an increase in glutamatergic 
synaptic currents. These abnormally 
located ectopic granule cells in the hilum 
may contribute to the increased excitability 
of the hippocampal tissue. Repeated 
seizures can trigger a persistent decrease in 
GABA flow in the hippocampus and 
neocortex, resulting in increased excitation 
in the neocortex. Nevertheless, when tested 
whether neuronal loss was directly related 
to cognitive impairment in experimental 
animals, only a weak correlation was 
found.2 Therefore, it cannot be concluded 
that one single factor can cause cognitive 
impairment in epilepsy patients. 
 Majority of patients with cognitive 
dysfunction in this study had consumed 
AED for ≥2 years although statistical 
analysis did not find a significant 
relationship between these two variables. 
Park and Kwon's study examined cognitive 
impairment in epileptic patients who had 
taken AED for at least 1 year and did not 
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find conclusive results even though the 
majority of previous studies indicated that 
long-term use of OAE (without a clear time 
limit) caused cognitive decline. Antiepiletic 
regimens may affect cognition by 
suppressing neuronal excitability or 
increasing inhibition of neurotransmission. 
The effect of AED on cognitive function 
appears to be dosage-dependent and is 
mainly exacerbated by polytherapy. On 
monotherapy and when serum AED levels 
are within a safe therapeutic range, this 
cognitive dysfunction tends to be mild.12 
The study by Miller et al also found that the 
amount of AED consumed was associated 
with cognitive impairment, especially in the 
language and visuospatial domains.15 In 
this study, the comparison of epilepsy 
patients with cognitive impairment who 
received polytherapy and monotherapy was 
not much different, although more people 
received polytherapy.  
 Among the early generations of 
AED carbamazepine, phenytoin and 
valproic acid exhibits a relatively similar 
effect on cognitive function, whereas 
phenobarbital clearly has a greater effect on 
cognitive impairment. The effect of the new 
generation of AED on cognitive function 
appears to be better than that of the earlier 
generation. Studies show that gabapentin, 
lamotrigine, and levetiracetam have fewer 
side effects on cognitive function when 
compared to carbamazepine.14 Among the 
newer AED generations, topiramate was 
associated with a greater risk of developing 
cognitive impairment although this risk was 
decreased with the administration of the 
drug via slow titration and low target dose. 
The current study did not describe the 
therapeutic regimens consumed by the 
subjects so that it could not analyze the 
relationship between certain AED and 
cognitive function in patients with focal 
epilepsy. Cognitive abnormalities due to 
AED generally involve attention, 
psychomotor speed and memory domains. 
Another study showed that IQ, learning 
performance and mood status were 
generally the same in epilepsy patients and 
the control group while working memory, 
executive function and verbal fluency were 
impaired in the patient group. In Park and 
Kwon study, it appears that cognitive 
deficits also do not correlate with patient 
characteristics, epilepsy variables or the 
type of OAE, similar to this study.12   
 Although available data suggest that 
cognitive impairment in epileptic patients is 
dependent on the pathophysiology of the 
seizure itself, for example, patients with 
temporal lobe epilepsy are likely to 
experience memory impairment or frontal 
lobe epilepsy patients tend to have 
problems with their executive function,5 the 
current study was unable to find a direct 
correlation between locations of focal 
epilepsy syndrome and cognitive function. 
The differences in the neuropsychiatric 
tools used may have contributed to this 
difference in results, in addition to the 
analysis in this study did not go deep into 
the comparison of function in each 
cognitive domain. In structural epilepsy, 
such as those caused by head trauma, 
stroke, and encephalitis, this underlying 
cause plays a role in the decline in cognitive 
function especially when the deficit is in 
line with the location of the lesion. 
Pathogenesis of focal epilepsy of unknown 
cause is much more complex. This study 
does not describe the etiology of epilepsy 
because not all subjects have undergone a 
complete examination such as magnetic 
resonance imaging / MRI to find out the 
exact cause of their focal epilepsy 
syndrome. In addition, focal epilepsy 
syndrome does not always represent the 
ictal and interictal electrical manifestations. 
The locations of abnormal electrical bursts 
during seizures and between seizures are 
often difficult to localize because they are 
simultaneously connected to various areas 
of the brain, allowing a rapid and wide-
spread epileptic activity.6 This research was 
conducted in the midst of the COVID-19 
pandemic where the number of hospital 
visits greatly decreased. The sample 
obtained in this study did not reach the 
calculated minimum sample size (68 
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samples) and had to combine primary data 
and secondary data from medical records. 
Cognitive function is based on the MoCA-
Ina score only because this test is routinely 
performed in all epilepsy patients as a 
screening tools so that data is generally 
available, while other tests are selective 




There was no significant direct 
correlation between cognitive function and 
the location of focal epilepsy. Cognitive 
function in epilepsy patients is not 
influenced by one single factor but is 
multifactorial starting from the patient's 
own characteristics, the type of epilepsy, 
and the AED used. For further reasearch, a 
similar study can be carried out using an 
adequate sample size, a variety of 
neurocognitive examinations and a more in-
depth analysis in order to find out what 
factors mainly affect cognitive function in 
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